An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma

Figure 7

Kaplan–Meier curves of overall survival in patients from the subgroup of (a) ＜60 years old, (b) ≥60 years old, (c) AST level ≤ 40 U/L, (d) AST level ＞ 40 U/L, (e) Child–Pugh A, and (f) Child–Pugh B stratified by the risk strata; AST, aspartate aminotransferase.

(a)

(b)

(c)

(d)

(e)

(f)